Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy

OBJECTIVE: Little is known about seizures in natalizumab-associated progressive multifocal leukoencephalopathy (NAT-PML). METHODS: A review of clinical records of 15 NAT-PML patients with multiple sclerosis (MS) treated at a German university hospital. RESULTS: Some 53% (8/15) of our patients develo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hoepner, Robert, Dahlhaus, Stefanie, Kollar, Susanne, Zurawski, Barbara, Chan, Andrew, Kleiter, Ingo, Gold, Ralf, Hellwig, Kerstin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2014
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3886383/
https://ncbi.nlm.nih.gov/pubmed/24409198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285613503515
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia